189 related articles for article (PubMed ID: 20617279)
21. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
22. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
[TBL] [Abstract][Full Text] [Related]
23. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
[TBL] [Abstract][Full Text] [Related]
24. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 1.0.
Fukukita H; Senda M; Terauchi T; Suzuki K; Daisaki H; Matsumoto K; Ikari Y; Hayashi M
Ann Nucl Med; 2010 May; 24(4):325-34. PubMed ID: 20401547
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
26. Appropriate indications for positron emission tomography/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.
Sathekge M; Warwick JM; Doruyter A; Vorster M
S Afr Med J; 2015 Nov; 105(11):894-6. PubMed ID: 26632309
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT.
Jallow N; Christian P; Sunderland J; Graham M; Hoffman JM; Nye JA
J Nucl Med; 2016 Feb; 57(2):238-41. PubMed ID: 26564326
[TBL] [Abstract][Full Text] [Related]
28. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
29. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
31. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
32. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.
Varrone A; Asenbaum S; Vander Borght T; Booij J; Nobili F; Någren K; Darcourt J; Kapucu OL; Tatsch K; Bartenstein P; Van Laere K;
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2103-10. PubMed ID: 19838705
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
34. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
35. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
36. [Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].
Dietlein M; Grünwald F; Schmidt M; Schneider P; Verburg FA; Luster M
Nuklearmedizin; 2016 Dec; 55(6):213-220. PubMed ID: 27922153
[TBL] [Abstract][Full Text] [Related]
37. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
38. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
40. Variability of [18F]FDG administered activities among patients undergoing PET examinations: an international multicenter survey.
Del Sole A; Lecchi M; Lucignani G
Radiat Prot Dosimetry; 2016 Mar; 168(3):337-42. PubMed ID: 25994847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]